Showing results (131-140 of 352) with videos related to
Sort By:
Pageof 36
Health Policy (Amsterdam, Netherlands)|July 26, 2020
Mortality and healthcare resource utilization following acute myocardial infarction according to adherence to recommended medical therapy guidelinesYgal Plakht, Dan Greenberg, Harel Gilutz, et al.Journal of Clinical Medicine|August 9, 2020
Associations between Subsequent Hospitalizations and Primary Ambulatory Services Utilization within the First Year after Acute Myocardial Infarction and Long-Term MortalityYgal Plakht, Dan Greenberg, Harel Gilutz, et al.Current Medical Research and Opinion|January 17, 2019
Healthcare-service utilization and direct costs throughout ten years following acute myocardial infarction: Soroka Acute Myocardial Infarction II (SAMI II) projectYgal Plakht, Harel Gilutz, Jonathan Eli Arbelle, et al.Pharmacoeconomics|June 20, 2019
Correction to: Publication of Decision Model Source Code: Attitudes of Health Economics AuthorsJoanna Emerson, Rachel Bacon, Alma Kent, et al.Health Affairs (Project Hope)|January 6, 2010
Cancer therapy costs influence treatment: a national survey of oncologistsPeter J Neumann, Jennifer A Palmer, Eric Nadler, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 26, 2018
Review of Recent US Value Frameworks-A Health Economics Approach: An ISPOR Special Task Force Report [6]Richard J Willke, Peter J Neumann, Louis P Garrison, et al.Health Affairs (Project Hope)|November 19, 2020
Consideration Of Value-Based Pricing For Treatments And Vaccines Is Important, Even In The COVID-19 PandemicPeter J Neumann, Joshua T Cohen, David D Kim, et al.BMJ Global Health|March 6, 2020
Are low and middle-income countries prioritising high-value healthcare interventions?Ashley A Leech, David D Kim, Joshua T Cohen, et al.American Journal of Preventive Medicine|October 17, 2015
Cost-Utility Analysis of Cancer Prevention, Treatment, and Control: A Systematic ReviewAaron N Winn, Donatus U Ekwueme, Gery P Guy, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2013
Willingness to pay for diagnostic technologies: a review of the contingent valuation literaturePei-Jung Lin, Michael J Cangelosi, David W Lee, et al.Pageof 36